Applied DNA Receives Extension from Nasdaq
October 3rd, 2019
Applied DNA Receives Extension from Nasdaq
October 3rd, 2019
iCTC Platform Shows Superior Correlation over PSA as a Biomarker
October 1st, 2019
APDN Receives $1 M SigNature T Taggant Order for 2019-20 Cotton Harvest Season
September 24th, 2019
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
September 19th, 2019
APDN Extends Forms Partnership with Industry Leader Navarpluma
September 5th, 2019
APDN Reports FY’19 Q3 Results
August 13th, 2019
Applied DNA Reports Fiscal Third Quarter 2019 Financial Results
August 13th, 2019
Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx
August 12th, 2019
LineaRx Acquires Assets and Intellectual Property of Vitatex
August 8th, 2019

Our new ticker symbol is ‘BNBX’. Learn more here.